Clinical Trial Update: A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil [Phase 1]

View source ↗

Summary

A phase 1 study evaluating the safety and tolerability of ASP0777 in individuals with Alzheimer's disease who are taking a stable dose of donepezil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ASP0777
• Donepezil (donepezil)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED